Income Tax Expense (Benefit) in USD of ABVC BIOPHARMA, INC. from 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Abvc Biopharma, Inc. quarterly/annual Income Tax Expense (Benefit) history and change rate from 2011 to Q3 2025.
  • Abvc Biopharma, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was $527.000, a 48.5% increase year-over-year.
  • Abvc Biopharma, Inc. annual Income Tax Expense (Benefit) for 2024 was -$111K, a 143% decline from 2023.
  • Abvc Biopharma, Inc. annual Income Tax Expense (Benefit) for 2023 was $256K, a 67.9% decline from 2022.
  • Abvc Biopharma, Inc. annual Income Tax Expense (Benefit) for 2022 was $798K, a 3.3% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

ABVC BIOPHARMA, INC. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $527 +$172 +48.5% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-03
Q2 2025 $23.6K +$135K Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-13
Q3 2024 $355 +$1.35K Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-03
Q2 2024 -$111K -$193K -236% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-13
Q3 2023 -$999 -$5.22K -124% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $81.7K +$164K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q4 2022 $798K $963K -$48.4K -4.79% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $846K $4.22K +$79.9K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-15
Q2 2022 $766K -$82.5K -$22.9K -38.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $789K -$86.9K -$35.8K -70.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $825K $1.01M +$1.1M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$273K -$75.7K -$30.9K -69.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$242K -$59.6K -$10.9K -22.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$231K -$51K -$10.5K -25.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$220K -$86.4K -$59.2K -217% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$161K -$44.7K -$93.3K -192% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$67.9K -$48.6K -$7.85K -19.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$60.1K -$40.6K +$17K +29.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$77K -$27.3K +$97.6K +78.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$175K $48.6K +$118K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-17
Q2 2019 -$292K -$40.8K +$36.1K +46.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$328K -$57.5K +$36.7K +39% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-29
Q4 2018 -$365K -$125K Oct 1, 2018 Dec 31, 2018 10-K 2020-05-15
Q3 2018 -$69.1K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-18
Q2 2018 -$76.9K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$94.3K -$95.1K -11459% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-28
Q1 2017 $830 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q2 2016 $836 +$836 Apr 1, 2016 Jun 30, 2016 10-Q 2018-03-19
Q2 2015 $0 $0 Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-19
Q1 2015 $0 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2015-06-05
Q4 2014 $0 $0 Oct 1, 2014 Dec 31, 2014 10-Q 2015-04-17
Q2 2014 -$135K $0 -$67.6K -100% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-19
Q1 2014 -$67.6K $0 -$67.6K -100% Jan 1, 2014 Mar 31, 2014 10-Q 2015-06-05
Q4 2013 $0 $0 $0 Oct 1, 2013 Dec 31, 2013 10-Q 2015-04-17
Q3 2013 $0 -$135K -$203K -300% Jul 1, 2013 Sep 30, 2013 10-K 2015-04-16
Q2 2013 $203K $67.6K +$67.6K Apr 1, 2013 Jun 30, 2013 10-Q 2015-04-17
Q1 2013 $135K $67.6K +$67.6K Jan 1, 2013 Mar 31, 2013 10-Q 2015-04-17
Q4 2012 $67.6K $0 $0 Oct 1, 2012 Dec 31, 2012 10-Q 2015-04-17
Q3 2012 $67.6K $67.6K Jul 1, 2012 Sep 30, 2012 10-K 2015-04-16
Q2 2012 $0 Apr 1, 2012 Jun 30, 2012 10-Q 2015-04-16
Q1 2012 $0 Jan 1, 2012 Mar 31, 2012 10-Q 2015-04-16
Q4 2011 $0 Oct 1, 2011 Dec 31, 2011 10-Q 2015-04-16

ABVC BIOPHARMA, INC. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$111K -$367K -143% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-15
2023 $256K -$542K -67.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-15
2022 $798K -$27.2K -3.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $825K +$1.05M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$220K -$143K -186% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$77K +$288K +78.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 -$365K -$366K -44088% Jan 1, 2018 Dec 31, 2018 10-K 2020-05-15
2017 $830 -$6 -0.72% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-15
2016 $836 Oct 1, 2015 Sep 30, 2016 10-KT 2018-04-13
2013 $0 -$67.6K -100% Oct 1, 2012 Sep 30, 2013 10-K 2015-04-16
2012 $67.6K +$67.6K Oct 1, 2011 Sep 30, 2012 10-K 2015-04-16
2011 $0 Oct 1, 2010 Sep 30, 2011 10-K 2015-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.